| Code | Description | Claims | Beneficiaries | Total Paid |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
2,437 |
2,274 |
$36K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
963 |
936 |
$19K |
| 78431 |
|
55 |
55 |
$17K |
| 78815 |
Positron emission tomography (PET) for limited area imaging |
25 |
25 |
$10K |
| 78608 |
|
15 |
15 |
$6K |
| A9552 |
Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries |
87 |
87 |
$5K |
| A9555 |
Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries |
28 |
28 |
$4K |
| 71250 |
|
146 |
146 |
$4K |
| 75571 |
|
273 |
271 |
$3K |
| 70551 |
Magnetic resonance imaging, brain; without contrast material |
67 |
67 |
$2K |
| 93015 |
|
44 |
44 |
$1K |
| 70544 |
|
36 |
36 |
$1K |
| 78434 |
|
53 |
53 |
$854.51 |
| 71270 |
|
28 |
28 |
$834.72 |
| 74178 |
|
28 |
28 |
$778.88 |
| A9577 |
Injection, gadobenate dimeglumine (multihance), per ml |
142 |
132 |
$609.31 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
254 |
253 |
$591.74 |
| J2785 |
Injection, regadenoson, 0.1 mg |
16 |
16 |
$36.80 |